APA (7th ed.) Citation

Schubert, M., Dietrich, S., Schmitt, A., Kunz, A., Bondong, A., Stadtherr, P., . . . Dreger, P. (2020). Feasibility and safety of CD19 chimeric antigen receptor T cell treatment for B cell lymphoma relapse after allogeneic hematopoietic stem cell transplantation. Biology of blood and marrow transplantation, 26(9), . https://doi.org/10.1016/j.bbmt.2020.04.025

Chicago Style (17th ed.) Citation

Schubert, Maria-Luisa, et al. "Feasibility and Safety of CD19 Chimeric Antigen Receptor T Cell Treatment for B Cell Lymphoma Relapse After Allogeneic Hematopoietic Stem Cell Transplantation." Biology of Blood and Marrow Transplantation 26, no. 9 (2020). https://doi.org/10.1016/j.bbmt.2020.04.025.

MLA (9th ed.) Citation

Schubert, Maria-Luisa, et al. "Feasibility and Safety of CD19 Chimeric Antigen Receptor T Cell Treatment for B Cell Lymphoma Relapse After Allogeneic Hematopoietic Stem Cell Transplantation." Biology of Blood and Marrow Transplantation, vol. 26, no. 9, 2020, https://doi.org/10.1016/j.bbmt.2020.04.025.